Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

190 Views

248. Treatment of Antimicrobial-Resistant Infections: Saturday, 12:15 - 1:30 p.m.

Poster Session: Treatment of Antimicrobial-Resistant Infections

(2752) Outcomes of Patients with Stenotrophomonas maltophilia infections treated with Cefiderocol in PROVE (Retrospective Cefiderocol Chart Review) Study

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Stephen Marcella, MD, MPH

Director
Shionogi Inc
Florham Park, New Jersey, United States
BF

Bruce Friedman, MD

Critical Care and Co-Director
Joseph M. Still Burn Center
Augusta, Georgia, United States

SV

Stefano Verardi, MD

Director
Shionogi, B.V.
London, England, United Kingdom
LG

Laurence Gozalo, PhD

Senior Scientist
Genesis Research
Hoboken, New Jersey, United States
Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States